With the rapid acceleration of telehealth solutions brought about by the pandemic, one company is uniquely servicing a key demographic- expectant mothers. Medtech HeraMED (ASX: HMD) is moving obstetric care into 2021 with their comprehensive digital health platform, HeraCARE and associated fetal and maternal heart rate monitor, HeraBEAT. The clinically validated tech allows for remote
Read More
Where kids of yesteryear might have been labelled shy due to hesitations in social situations, coming generations of children will be classified as having Social Anxiety Disorder as a result of hypervigilant parenting in the digital age. While some will be self-treated via social experimentation, others will struggle without medical intervention which is just one
Read More
Good things come in small packages, like PharmAust’s (ASX: PAA) newest iteration of their monepantel (MPL) tablets. The clinical stage biotechnology company has manufactured smaller versions of their lead asset, MPL, a potent small molecule drug that has been shown to affect key pathways associated with cancer and other diseases. PharmAust have studied MPL for
Read More
Our minds can be our greatest asset and our biggest enemy. The same humans that built aeroplanes, rockets and the internet are just as prone to ailments like depression, anxiety and functional cognitive decline. Unfortunately when it comes to cognition, doing the odd sudoku probably won’t cut it if you’re hoping to maintain your current
Read More
We are all different. It’s what makes us unique. Companies are all too aware of this, with experiences and products evolving to cater to personal needs and preferences. From mixing custom skin care formulations to Spotify music recommendations, personalised experiences are more memorable and valuable to the customer. The same goes for medicine. Personalisation means
Read More